top of page
Q-Line Biotech Limited
IPO Type:
SME
Status:
Listed
Sector:
Biotechnology / Diagnostics / In-Vitro Diagnostics / Healthcare
Exchange:
NSE SME
Q-Line Biotech Limited is a Baroda, Gujarat-based biotechnology and diagnostics company incorporated in 2013, specialising in manufacturing and supplying In-Vitro Diagnostic (IVD) products including medical diagnostic equipment, reagents, rapid test kits, and pathology instruments. Serves 150+ national and international clients across 15 years in the diagnostic industry. 362 permanent employees + 223 contract employees as of March 2026. Raised ₹27.44 Cr in pre-IPO placement of 8 lakh shares at ₹343 per share in May 2026. Revenue ₹322.58 Cr (FY25) vs ₹206.45 Cr (FY24), PAT ₹28.13 Cr (FY25) vs ₹34.44 Cr (FY24). IPO proceeds: working capital ₹93.50 Cr, debt repayment ₹90 Cr, general corporate purposes.
Issue Size (Cr)
214.48
9.87
x times original subscription
452
Listing Price (₹)
Issue Dates
May 21–25
Price Band
₹326 to ₹343
Allotment Date
26 May 2026
Listing Date
29 May 2026
Lot Size
400
QIB (times x)
5.19
NII (timex x)
10.95
Retail (times x)
10.07
Min Investment (₹)
274400
Registrar
Purva Sharegistry (India) Pvt Ltd
bottom of page